广发纳斯达克生物科技人民币(001092)

动态评分: 5.70分

投资组合

报告日期 名称 比例
2017-12-31 DBV Technologies SA ADR 0.07%
2017-12-31 GlycoMimetics Inc 0.07%
2017-12-31 G1 Therapeutics Inc 0.07%
2017-12-31 Iovance Biotherapeutics Inc 0.07%
2017-12-31 Chinook Therapeutics Inc 0.07%
2017-12-31 Reata Pharmaceuticals Inc-A 0.07%
2017-12-31 Rigel Pharmaceuticals Inc 0.07%
2017-12-31 Synergy Pharmaceuticals Inc 0.07%
2017-12-31 Voyager Therapeutics Inc 0.07%
2017-12-31 Achaogen Inc 0.06%
2017-12-31 AMAG Pharmaceutical Inc 0.06%
2017-12-31 Assertio Holdings Inc 0.06%
2017-12-31 BioCryst Pharmaceuticals Inc 0.06%
2017-12-31 Coherus BioSciences Inc 0.06%
2017-12-31 Cytokinetics Inc 0.06%
2017-12-31 卡拉制药 0.06%
2017-12-31 Karyopharm Therapeutics Inc 0.06%
2017-12-31 Kura Oncology Inc 0.06%
2017-12-31 Paratek Pharmaceuticals Inc 0.06%
2017-12-31 Savara Inc 0.06%

投资模拟

公告&资料